Synthesis, antiprotozoal activity and cytotoxicity in U-937 macrophages of triclosan–hydrazone hybrids
- 79 Downloads
The synthesis and biological activities (cytotoxicity, leishmanicidal, and trypanocidal) of 11 triclosan–hydrazone hybrids are described herein. The structure of the products was elucidated by spectral data (NMR, IR) and mass spectrometric analyses. The synthesized compounds were evaluated against amastigotes forms of L. (V) panamensis, which is the most prevalent Leishmania species in Colombia, and against Trypanosoma cruzi, which is the major pathogenic species to Chagas disease in humans. In addition, the cytotoxic activity of the synthesized compounds was evaluated against human U-937 macrophages. Hydrazone hybrids were obtained as E-synperiplanar and E-antiperiplanar conformers. Nine of them were active against L. (V) panamensis (5a–5d, 5f–5j) and eight of them against T. cruzi (5a, 5c, 5d, 5f–5j), with EC50 values lower than 40 µM. The compounds 5c, 5e, and 5h exhibit the best selectivity index against both L. (V) panamensis and T. cruzi, with values ranging from 5.90 to 16.55, thus showing potential as starting compounds for the eventual development of drugs against these parasites. The presence of hydroxy or methoxy groups in positions 2 and 4 of the aromatic ring of the benzylidene moiety increases both activity and cytotoxicity. There is no clear relationship between the antiprotozoal activity and the methylation pattern of the hydroxy groups, since in some cases methylation decreases the activity (5d vs. 5g) while in other cases the activity is increased (5c vs. 5f and 5i vs. 5j).
KeywordsLeishmaniasis Chagas disease Trypanosoma cruzi Antiprotozoal activity Cytotoxicity Triclosan-Hydrazone Hybrids
The authors thank COLCIENCIAS (contract no. 0333-2013, code: 111556933423) for financial support.
Compliance with ethical standards
Conflict of interests
The authors declare that they have no competing interests.
- Carvalho S, Feitosa L, Soares M, Costa T, Henriques MG, Salomão K, de Castro SL, Kaiser M, Brun R, Wardell JL, Wardell S, Trossini G, Andricopulo AD, da Silva EF, Fraga C (2012) Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents. Eur J Med Chem 54:512–521CrossRefPubMedGoogle Scholar
- Chatelain E, Ioset JR (2011) Drug discovery and development for neglected diseases: the DNDi model. Drug Des Dev Ther 16:175–181Google Scholar
- Finney JD (1978) Probit analysis: statistical treatment of the sigmoid response curve, 3rd edn. Cambridge University Press, Cambridge, UK, p 550Google Scholar
- Insuasty B, Ramirez J, Becerra D, Echeverry C, Quiroga J, Abonia R, Robledo SM, Velez ID, Upegui Y, Muñoz JA, Ospina V, Nogueras M, Cobo J (2015) An efficient synthesis of a new caffeine-based chalcones, pyrazolines and pyrazolo[3-4-b][1-4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents. Eur J Chem Med 93:401–413CrossRefGoogle Scholar
- Jorge SD, Palace-Berl F, Mesquita Pasqualoto KF, Ishii M, Ferreira AK, Berra CM, Bosch RV, Maria DA, Tavares LC (2013) Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents. Eur J Med Chem 64:200–214CrossRefPubMedGoogle Scholar
- Massarico Serafim RA, Gonçalves JE, de Souza FP, de Melo Loureiro AP, Storpirtis S, Krogh R, Andricopulo AD, Dias LC, Ferreira EI (2014) Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. Eur J Med Chem 82:418–425CrossRefPubMedGoogle Scholar
- McLeod R, Muench SP, Rafferty JB, Kyle DE, Mui EJ, Kirisits MJ, Mack DG, Roberts CW, Samuel BU, Lyons RE, Dorris M, Milhous WK, Rice DW (2001) Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan Fab I. Int J Parasitol 31:109–113CrossRefPubMedGoogle Scholar
- Singh M, Raghav N (2011) Biological activities of hydrazones: a review. Int J Pharm Pharm Sci 3:26–32Google Scholar
- Taylor VM, Cedeño DL, Muñoz DL, Jones MA, Lash TD, Young AM, Constantino MH, Esposito N, Vélez ID, Robledo SM (2011) In vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis. Antimicrob Agents Chemother 55:4755–4764CrossRefPubMedPubMedCentralGoogle Scholar
- WHO (2013) Why are Some Tropical Diseases Called ‘Neglected’? http://www.who.int/features/qa/58/en/. Accessed 12 Apr 2013.
- WHO (2002) Control of Chagas disease: second report of the WHO expert committee, vol 905. World Health Organization, Geneva, p 109. ISBN 9241209054. http://www.who.int/iris/handle/10665/42443Google Scholar